other material
confidence high
sentiment negative
materiality 0.75
Getaround, Inc: Nasdaq/NYSE listing notice — Getaround faces NYSE delisting for late 10-K; convertible note conversion price cut to $9.21
Getaround, Inc
- NYSE notified Getaround on Apr 18 of non-compliance for failing to file FY2022 10-K; 6-month cure period.
- Previously disclosed NYSE notices for stock price <$1 and market cap <$50M; cure periods ongoing.
- Conversion price on $175M convertible notes automatically adjusted to minimum $9.21 per share, effective Apr 21.
- Potential share dilution rises from ~15.2M to ~19.0M shares upon conversion of notes.
- Company intends to cure all deficiencies; no immediate delisting of common stock.